Arvinas (ARVN) Capital Expenditures (2018 - 2025)
Arvinas (ARVN) recorded quarterly Capital Expenditures of $200000.0 in Q4 2025, up 100.0% quarter-over-quarter from $100000.0 in Q3 2025, and down 33.33% on a YoY basis from $300000.0 in Q4 2024.
Arvinas (ARVN) Capital Expenditures (2018 - 2025) Analysis & Trends
Arvinas' Capital Expenditures history runs 8 years deep, the most recent figure standing at $200000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures fell 33.33% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $1.8 million (down 5.26% YoY), while the FY2025 annual figure was $1.9 million, up 5.56% from the prior year.
- Capital Expenditures was $200000.0 for Q4 2025 at Arvinas, up from $100000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $4.6 million in Q4 2021 to a low of -$2.8 million in Q4 2023.
- Historically, Capital Expenditures has averaged $447368.4 across 5 years, with a median of $200000.0 in 2025.
- Biggest YoY gain for Capital Expenditures was 1300.0% in 2023; the steepest drop was 1300.0% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $4.6 million in 2021, then plunged by 104.35% to -$200000.0 in 2022, then plunged by 1300.0% to -$2.8 million in 2023, then soared by 110.71% to $300000.0 in 2024, then sank by 33.33% to $200000.0 in 2025.
- The last three Capital Expenditures figures came in at $200000.0 (Q4 2025), $100000.0 (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Dec 31, 2023 | -2.80 Mn |
| Dec 31, 2023 | -2.80 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | -700,000.00 |
| Jun 30, 2023 | -700,000.00 |